The purpose of this systematic review was to identify the operative issues and specific dysmenorrhea and menorrhagia outcomes in women who had undergone fertility-sparing surgery, as well as determine the expected outcome for extirpative surgery. Data Sources: PROSPERO (ID no. 125692). Search was conducted for eligible studies up to March 31, 2019, on MED-LINE/PubMed (1966, Scopus/Elsevier (1950), and Google Scholar (up to 2019. The search terms applied for the search strategy were as follows: adenomyosis, adenomyomas, uterus-sparing surgery, fertility-sparing surgery, pain, dysmenorrhea, menorrhagia, uterine volume, adenomyotic volume, case-control studies, cohort studies, and prospective studies. Methods of Study Selection: A total of 443 studies were initially identified. Exclusion criteria was as follows: (1) inadequate description of preoperative adenomyosis or absence of postoperative histology confirmation of adenomyosis, (2) no statement of use of a standardized instrument for measurement of pain, bleeding, or adenomyotic/uterine volume, (3) follow-up <12 months postoperatively, (4) study population <20 women, and (5) non-English language. Tabulation, Integration, and Results: Nineteen studies with a total of 1843 patients with adenomyosis were included. Twelve studies were further analyzed in the meta-analysis. Complete excision of adenomyosis was associated with improvement in pain, menorrhagia, and reduction of uterine volume by a factor of 6.2, 3.9, and 2.3, respectively; the partial excision of adenomyosis was associated with improvement in pain, menorrhagia, and reduction of uterine volume by a factor of 5.9, 3.0, and 2.9, respectively; the studies with a mixed volume of patients with complete and partial excision of adenomyosis reported improvement in pain, menorrhagia, and reduction of uterine volume by a factor of 4.0, 6.3, and 5.1, respectively. Conclusion: The surgical treatment of adenomyosis results in the satisfactory control of pain and bleeding, as well as in the reduction of uterine volume. Further research is warranted to investigate the long-term control of symptoms to identify any parameters related to the recurrence of adenomyosis, as well as to compare the conservative surgical treatment of adenomyosis with other treatment options.
IntroductionPostmenopausal labial fusion constitutes a severe form of genitourinary syndrome of menopause. This report describes the management of a series of women with complete labial fusion (CLF) and pseudo-incontinence.MethodsThis is a seven-year retrospective chart review in a urogynaecology unit of a tertiary hospital of all who patients presented with CLF and lower urinary tract symptoms, predominantly continuous urinary incontinence. All patients had a standardized surgical intervention and were followed up in the outpatient department.ResultsSeven patients (mean age 72.9 ± 12.1 years) with CLF and associated pseudo-incontinence were identified from the hospital archives. All patients had an uneventful surgical restoration of the labial anatomy, the pseudo-incontinence had resolved immediately postoperatively in all cases, and no recurrence of the labial agglutination had occurred after an average follow-up of 2.4 years.ConclusionsIn this report we present a case series of seven postmenopausal patients with CLF and urinary pseudo-incontinence who underwent successful surgical management with good anatomical results and complete resolution of urinary symptoms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.